Susquehanna International Group
FOMX

Susquehanna International Group’s Foamix Pharmaceuticals Ltd. Ordinary Shares FOMX Stock Holding History

Susquehanna International Group’s Portfolio FOMX Stock Details FOMX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-37,300
Closed -$124K – 11309
2019
Q4 		$124K Buy
37,300
+17,700
+90% +$56.3K ﹤0.01% 9044
2019
Q3 		$60K Buy
+19,600
New +$55.1K ﹤0.01% 9736
2019
Q2 		– Sell
-28,800
Closed -$108K – 11164
2019
Q1 		$108K Sell
28,800
-13,400
-32% -$50.2K ﹤0.01% 8215
2018
Q4 		$151K Sell
42,200
-3,400
-7% -$14.8K ﹤0.01% 7976
2018
Q3 		$261K Buy
45,600
+18,400
+68% +$105K ﹤0.01% 7748
2018
Q2 		$136K Buy
27,200
+1,100
+4% +$5.66K ﹤0.01% 8908
2018
Q1 		$134K Buy
26,100
+900
+4% +$5.42K ﹤0.01% 8585
2017
Q4 		$151K Buy
+25,200
New +$152K ﹤0.01% 8486
2017
Q3 		– Sell
-34,100
Closed -$158K – 10006
2017
Q2 		$158K Buy
34,100
+15,700
+85% +$70.1K ﹤0.01% 8464
2017
Q1 		$91K Buy
+18,400
New +$177K ﹤0.01% 8427

Susquehanna International Group's FOMX Position: Q1 2020 in Review

Susquehanna International Group sold out of Foamix Pharmaceuticals Ltd. Ordinary Shares (FOMX) in Q1 2020, closing a stake of 74,496 shares — an estimated $248K sold.

Susquehanna International Group first reported a position in FOMX in Q2 2016 and held it in 9 quarters. The position peaked at $559K in Q3 2019. 3 funds tracked by Wall St. Rank hold FOMX as of Q1 2020.

  • Susquehanna International Group reported no remaining Foamix Pharmaceuticals Ltd. Ordinary Shares position as of Q1 2020 after selling out during the quarter.
  • Susquehanna International Group sold 74,496 Foamix Pharmaceuticals Ltd. Ordinary Shares shares in Q1 2020, an estimated $248K.
  • Susquehanna International Group first reported a position in Foamix Pharmaceuticals Ltd. Ordinary Shares in Q2 2016 and held it in 9 quarters.
  • Susquehanna International Group's Foamix Pharmaceuticals Ltd. Ordinary Shares position peaked at $559K in Q3 2019.
  • 3 funds tracked by Wall St. Rank held Foamix Pharmaceuticals Ltd. Ordinary Shares as of Q1 2020.

Based on Susquehanna International Group's 13F filing for Q1 2020, filed 15 May 2020.